Reviva Pharmaceuticals Holdings Inc (RVPH)
1.66
-0.05
(-2.92%)
USD |
NASDAQ |
May 17, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Cash from Operations (TTM): -32.10M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -32.10M |
December 31, 2023 | -28.32M |
September 30, 2023 | -24.14M |
June 30, 2023 | -21.96M |
March 31, 2023 | -20.65M |
December 31, 2022 | -18.96M |
Date | Value |
---|---|
September 30, 2022 | -18.17M |
June 30, 2022 | -16.48M |
March 31, 2022 | -13.82M |
December 31, 2021 | -10.67M |
September 30, 2021 | -9.702M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.10M
Minimum
Mar 2024
-9.702M
Maximum
Sep 2021
-19.54M
Average
-18.96M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
AbbVie Inc | 22.69B |
ABVC BioPharma Inc | -4.236M |
Sutro Biopharma Inc | -115.37M |
Flora Growth Corp | -8.396M |
Journey Medical Corp | 1.177M |